Table 2.

Demographic and clinical parameters and amplification of HIV-1 fragment of the study samples

PID	Age	Sex	Viral loada	CD4a	Therapy	Country of transmission	Route of transmissiona	F1Gag-Vpu	F2vif-3LTR
SE600001	51	Male	1,905,461	4	Naïve	Sweden	IVDU	+	+
SE600012	39	Male	707,946	190	Naïve	Sweden	MSM	+	+
SE600023	41	Male	194,984	150	Naïve	Sweden	Heterosexual	+	+
SE600034	52	Male	3,467,369	220	Naïve	Sweden	MSM	+	+
SE600035	44	Female	309,030	260	Naïve	Sweden	IVDU	+	+
SE600046	50	Male	6,606,934	9	Naïve	NA	MSM	+	+
SE600057	45	Male	50,400	180	Naïve	Sweden	Heterosexual	+	+
SE600063	45	Female	7600	316	Naïve	Sweden	Heterosexual	+	+
SE600068	40	Female	1300	421	Naïve	Sweden	NA	−	+
SE600099	27	Female	1120	510	Naïve	Sweden	Heterosexual	+	−
SE600108	35	Male	150,000	270	Naïve	Sweden	IVDU	+	+
SE600119	39	Male	158,000	184	Naïve	Ethiopia	Heterosexual	+	+
SE600210	42	Male	338,844	133	Naïve	Ethiopia	Heterosexual	+	+
SE600311	58	Male	3990	110	Experience	Ethiopia	Heterosexual	+	+
SE600412	58	Male	18,400	300	Naïve	Eritrea	Heterosexual	+	+
SE600213	25	Female	110,000	169	Naïve	Ethiopia	Heterosexual	+	+
SE600314	40	Female	219,000	400	Naïve	Zimbabwe	Heterosexual	+	+
SE600415	30	Male	575,000	125	Naïve	Eritrea	Heterosexual	+	+
SE600122	38	Female	6580	460	Naïve	Eretria	Heterosexual	+	+
SE600516	37	Female	1,000,000	304	Naïve	Sweden	Heterosexual	+	+
SE601017	34	Female	2,300,000	16	Naïve	Thailand	Heterosexual	+	+
SE601018	35	Female	260,000	350	Naïve	Thailand	Heterosexual	+	+
SE601021	40	Female	40,800	249	Naïve	Thailand	NA	+	+
SE602019	41	Female	129,000	400	Naïve	Senegal	Blood transfusion	+	+
SE602020	24	Female	162,000	90	Experience	Cameroon	Heterosexual	+	+
SE602024	35	Female	3060	360	Naïve	Cameroon	Heterosexual	+	+

^aViral load in copies/ml, CD4 in cells/mm³. IVDU: intravenous drug user; MSM: men who have sex with men; NA: not available.